ValuentumAd

Official PayPal Seal













Fundamental data is updated weekly, as of the prior weekend. Please download the Full Report and Dividend Report for any changes.
Dec 11, 2012
Inside AbbVie: A Look at a New Pharmaceutical Giant
Let's take a look at Abbott's new standalone business, AbbVie.
Dec 7, 2012
Enbridge Capitalizes on Fantastic Shale Oil Growth
Enbridge remains on track to grow its dividend going forward. We like the firm’s dividend, but think its shares are fairly valued.
Dec 7, 2012
Dividends at Financial Services Firms
We take a look at dividends from a few well-known firms in one of the hardest hit sectors of the Great Recession.
Dec 4, 2012
Toll Brothers' Fourth Quarter Results Were Fantastic
Homebuilder Toll Brothers reported a blowout fourth quarter, but we don’t like the firm’s valuation.
Dec 3, 2012
Are Any Rumored Buyouts Worth Betting On?
We’re not seeing many that meet our criteria, but we take a look at some recent M&A whispers.
Dec 2, 2012
Valuentum's December Edition of Its Dividend Growth Newsletter!
The December edition of our Dividend Growth Newsletter is now available.
Nov 29, 2012
November Retail Sales Disappoint
Retail sales were a little light in November. Let's take a look at the results.
Nov 28, 2012
Green Mountain Posts Strong Revenue Growth
Boosted by K-cup sales, Green Mountain posted solid sales and better than expected earnings.
Nov 27, 2012
Solid Cyber Monday
Let’s take a look at sales from Cyber Monday.
Nov 22, 2012
Deere Posts Decent Sales Growth, But Profitability Disappoints
Increases in R&D expenses and SG&A weigh on profits, but sales are strong. We think shares of Deere are fairly valued.


The High Yield Dividend Newsletter, Best Ideas Newsletter, Dividend Growth Newsletter, Nelson Exclusive publication, and any reports, articles and content found on this website are for information purposes only and should not be considered a solicitation to buy or sell any security. The sources of the data used on this website are believed by Valuentum to be reliable, but the data’s accuracy, completeness or interpretation cannot be guaranteed. Valuentum is not responsible for any errors or omissions or for results obtained from the use of its newsletters, reports, commentary, or publications and accepts no liability for how readers may choose to utilize the content. Valuentum is not a money manager, is not a registered investment advisor and does not offer brokerage or investment banking services. Valuentum, its employees, and affiliates may have long, short or derivative positions in the stock or stocks mentioned on this site.